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Abstract. C-Glycopyranosyl styrene type compounds are 
valuable synthetic intermediates whose syntheses are known 
in rather lengthy procedures. Herein palladium-catalyzed 
cross-couplings of O-peracylated 2,6-anhydro-aldose 
tosylhydrazones with benzyl bromides were studied under 
thermic conditions in the presence of LiOtBu. The reactions 
gave the corresponding C-glycopyranosyl styrenes in up to 
59 % yields. The transformations represent a new, short 
synthetic sequence to get this type of glycomimetic 
compounds in 4-5 steps from a free aldose. 
Keywords: Alkenes; Anhydro-aldose tosylhydrazones; 
Carbenes; Carbohydrates; Cross-coupling; C-C coupling; 
C-Glycosides. 
Introduction 
C-Glycosyl compounds are present in nature, among 
synthetic derivatives, and active ingredients of marketed 
drugs, and their chemistry as well as already realized and 
potential applications have been comprehensively 
reviewed recently.[1-3] 
Among many types of C-glycosyl derivatives C-
glycosyl styrenes F (Scheme 1) are versatile starting 
compounds of e. g. C-glycosyl-aldehydes (highly 
appreciated intermediates for the synthesis of complex C-
glycosyl derivatives),[4-6] cis- and trans-fused allylic and 
vinylic bicyclic ethers,[7, 8] (structural elements of marine 
toxins[9]), pyranopyran carbohydrate amino acids (building 
blocks of glyco- and peptidomimetic compounds),[10, 11] 
analogues of uridine-5’-diphosphate (UDP) sugar 
derivatives[12] (potential glycosyltransferase inhibitors), C-
linked glycosyl coumarins and isocoumarins[13] (e. g. 
antibacterial, anticancer agents) and (parts of) natural 
products such as ambruticin[5] (an antifungal antibiotic) or 
lasonolide A[14] (anticancer activity). 
The known synthetic routes to access C-glycopyranosyl 
styrenes F are summarized in Scheme 1. One of the 
applied approaches is the construction of the C-C bond 
between the anomeric carbon and the aglycon part of the 
molecules. Among these methods inter- and intramolecular 
variants can also be found. Thus, the intermolecular 
possibility is represented by the direct C-glycosylation of 
glycosyl fluoride A with potassium styryl trifluoroborate,[9] 
the irradiation of glycosylcobaloximes B in the presence of 
alkenes,[15] while in the intramolecular approaches radical-
induced cyclization of the 2-phenylethynylsiloxy-
glucopyranosylphenylselenide[16] C or 2-alkynylsiloxy-
glycopyranosylphenylsulfones[17] D followed by 
desilylation gave styrenes F. 
The most frequently applied method for the preparation 
of C-glycopyranosyl styrenes F is the partial reduction of 
the acetylene moiety in E by employing Lindlar catalyst[4, 7, 
8, 10, 11] or zinc.[18] Arylethynyl derivatives E can be 
obtained directly from a glycopyranosyl bromide or 
chloride or in a two-step reaction from 1,2-anhydro 
aldopyranose derivatives or lactones, as detailed in the 
above references. 
In other syntheses the construction of the C=C bond in 
styrenes F are realized in one step: dehydration reaction of 
O-perbenzylated or O-peracetylated 1-phenyl-2-(-D-
glucopyranosyl)ethanol H, prepared from free aldoses in 
three-step reactions[6] or the Julia olefination of the O-
perbenzylated -C-glucopyranosyl aldehyde I resulted in 
C-glycopyranosyl styrenes F.[13] Another possibility is the 
formation of the C=C bond in a cross-metathesis reaction 
between a vinyl -C-D-galactopyranoside J with alkenes in 
the presence of Hoveyda-Grubbs II catalyst and CuI.[19]
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Scheme 1. Synthetic routes toward C-glycopyranosyl styrenes F (for details see text). 
From a synthetic point of view, most of the above 
methods lack generality, need special starting materials or 
reagents prepared in lengthy reaction sequences, therefore, 
a mild catalytic methodology to prepare C-glycopyranosyl 
styrene derivatives from starting compounds easily 
available in any monosaccharide configuration would be 
desirable. 
In the last decade tosylhydrazones emerged as reaction 
partners in various cross-coupling reactions.[20-24] In recent 
years we have studied the utility of anhydro-aldose 
tosylhydrazones G readily obtained from glycosyl 
cyanides.[25-27] Thus, metal free couplings of G with 
alcohols, phenols, carboxylic acids,[28] and thiols,[29] as 
well as Pd-catalyzed cross couplings with aryl bromides[30] 
were studied. Herein we disclose our experiences with Pd-
catalyzed reactions between G and benzyl bromides which 
provide a new, alternative, and shorter reaction pathway to 
C-glycopyranosyl styrenes F. 
Results and Discussion 
At the outset, we chose O-perbenzoylated C-(-D-
glucopyranosyl)formaldehyde tosylhydrazone 1[26, 27] and 
benzyl bromide as the substrates to optimize the reductive 
coupling reaction (Table 1). Initially, it was observed that 
using 5 mol% (Pd(OAc)2) with (LiOtBu) as the base in 
1,4-dioxane at 70 oC the expected coupling product 2a 
could be isolated, albeit in only very low yield (Table 1, 
entry 1). Other ligands such as di(1-adamantyl)-n-
butylphosphine (CataCXium A) and 1,3-
bis(diphenylphosphino)propane (DPPP) were found to be 
also effective (entries 3 and 5, respectively), however, the 
yield did not improve. On the other hand tri(2-
furyl)phosphine (P(2-furyl)3) and 1,1’-ferrocenediyl-
bis(diphenylphosphine) (DPPF) gave somewhat better 
results (entries 2 and 4, respectively). Performing the 
reaction with 2.5 mol% 
tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3) 
catalyst in the presence of P(2-furyl)3 and LiOtBu in 1,4-
dioxane at reflux temperature or in toluene at 80 °C as 
suggested in the literature for aromatic coupling partners[31] 
gave compound 2a in very low (entry 6) or moderate yield 
(entry 7), respectively. Further optimization of the reaction 
conditions revealed that the yields could be significantly 
improved by raising the amount of benzyl bromide (entries 
8 and 9). The optimized reaction conditions are shown in 
entry 9, under which the coupling product 2a could be 
obtained in 48% yield. In almost every cases the formation 
of exo-glucal 3 and N-benzylated tosylhydrazone 4a as by-
products were observed.  
With the optimized conditions in hand, the scope of the 
reaction was first explored with tosylhydrazone 1 and a 
variety of substituted benzyl bromides (Table 2). The 
reactions afforded the corresponding styrenes in low to 
medium yields. The substitution pattern of the aromatic 
ring with electron-donating and electron-withdrawing 
groups and ortho, meta or para position of the substituents 
had only a moderate effect on the yields (entries 1-10). 
Similarly to previous findings, the formation of exo-glucal 
3 and N-benzylated tosylhydrazone 4 could never be 
avoided. Further by-products having no carbohydrate 
residue were also observed in these reactions, and in one 
case, from the reaction in entry 3, this compound was 
isolated and proved to be 3-methoxybenzyl-4-
methylphenyl-sulfone 5c clearly formed by the reaction of 
the toluenesulfinate anion with the corresponding benzyl 
bromide (see mechanistic proposal later). 
A further optimization was performed with 4-
cyanobenzyl bromide (Table 3) which was the reagent in 
one of the relatively low yielding reactions. Application of 
a higher ratio of the Pd2(dba)3 catalyst (10 mol%) and the 
P(2-furyl)3 ligand (40 mol%) resulted in somewhat better 
yields (entry 2). Nevertheless, raising the quantities in an 
10.1002/adsc.201801059
Ac
ce
pt
ed
 M
an
us
cr
ip
t
Advanced Synthesis & Catalysis
This article is protected by copyright. All rights reserved.
 3 
extraordinary way (50 mol% Pd2(dba)3 catalyst and 400 
mol% P(2-furyl)3 ligand, entry 3) doubled the yield.  
Application of 40 mol% P(2-furyl)3 ligand with various 
Pd-catalysts did not affect the yields significantly (entries 
4-7). Next, the effect of the ligands was also examined. 
The use of Pd2(dba)3 catalyst (10 mol%) with CataCXium 
A, DPPF and 2-dicyclohexylphosphino-2’,4’,6’-
triisopropylbiphenyl (XPhos) diminished the yields (entries 
8, 10, 11, respectively), nevertheless, better results were 
achieved with DPPP and PPh3 (entries 9, 12). Similarly to 
the other reactions, formation of by-products 3, 4j and type 
5 could not be avoided. 
 
 
 
Table 1. Optimization of reaction conditions  
 
Entry 
Pd catalyst  
(mol %) 
Ligand  
(mol %) 
Ph-CH2-Br 
(equiv.) 
LiOtBu 
(equiv.) 
Solvent 
T 
(°C) 
Yield (%) 
2 3 4 
1 Pd(OAc)2 (5) XPhos (20) 1 3 1,4-dioxane 70 3 15 4 
2 Pd(OAc)2 (5) P(2-furyl)3 (20) 1 3 1,4-dioxane 70 25 
in 
traces 
nda 
3 Pd(OAc)2 (5) CataCXium A (20) 1 3 1,4-dioxane 70 3 4 
in 
traces 
4 Pd(OAc)2 (5) DPPF (20) 1 3 1,4-dioxane 70 24 2 
in 
traces 
5 Pd(OAc)2 (5) DPPP (20) 1 3 1,4-dioxane 70 3 7 
in 
traces 
6 Pd2(dba)3 (2.5) P(2-furyl)3 (20) 1 3 1,4-dioxane 101 4 nda nda 
7 Pd2(dba)3 (2.5) P(2-furyl)3 (20) 1 3 toluene 80 32 2 3 
8 Pd2(dba)3 (2.5) P(2-furyl)3 (20) 3 1.5 1,4-dioxane 70 22 nda nda 
9 Pd2(dba)3 (2.5) P(2-furyl)3 (20) 6 1.5 1,4-dioxane 70 48 11 nda 
a Not detectable 
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Table 2. Pd-catalyzed coupling of tosylhydrazone 1 with benzyl bromides  
 
Entry  R 
R-C6H4-CH2-Br 
(equiv.) 
LiOtBu 
(equiv.) 
Yield (%) 
2 3 4 
1 a H 6 1.5 48 11 nda 
2 b 4-CH3 6 1.5 40 6 11 
3b c 3-CH3O 6 1.5 10 nda 31 
4 d 4-Cl 6 1.5 40 5 14 
5 e 3-Cl 6 1.5 42 6 nda 
6 f 4-Br 6 1.5 54 4 nda 
7 g 3-Br 6 1.5 32 11c 5 
8 h 2-Br 6 1.5 36 20 2 
9 i 4-NO2 6 1.5 20d 
in 
traces 
16c 
10 j 4-CN 6 1.5 27 16c 17c 
a Not detectable 
b By-product containing no carbohydrate residue isolated from the reaction: 
 
 
5c 
 
c Yields calculated on the basis of the 1H NMR spectra of the worked-up reaction mixture. 
d Based on the 1H NMR spectrum of the crude mixture formation of an equal amount of the Z isomer was observed. 
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Table 3. Optimization of the reaction conditions of Pd-catalyzed coupling of tosylhydrazone 1 with 4-cyanobenzyl 
bromide 
 
Entry 
Pd catalyst 
(mol %) 
Ligand 
(mol %) 
4-CN-C6H4-CH2-Br 
(equiv.) 
LiOtBu 
(equiv.) 
Yield (%) 
2j 3 4j 
1 Pd2(dba)3 (2.5) P(2-furyl)3 (20) 6 1.5 27 16a 17a 
2 Pd2(dba)3 (10) P(2-furyl)3 (40) 3 1.5 35 12 21 
3 Pd2(dba)3 (50) P(2-furyl)3 (400) 6 1.5 55 5 7 
4 Pd(OAc)2 (19) P(2-furyl)3 (40) 6 1.5 32 10 18 
5 Pd(CH3CN)2Cl2 (10) P(2-furyl)3 (40) 6 1.5 30 4 20 
6 Pd(PPh3)2Cl2 (10) P(2-furyl)3 (40) 6 1.5 36 1 53 
7 Pd(PPh3)4 (10) P(2-furyl)3 (40) 6 1.5 24 16 27 
8 Pd2(dba)3 (10) CataCXium A (40) 6 1.5 14 13 63 
9 Pd2(dba)3 (10) DPPP (40) 6 1.5 42a 20 29a 
10 Pd2(dba)3 (10) DPPF (40) 6 1.5 22a 
in 
traces 
28a 
11 Pd2(dba)3 (10) XPhos (40) 6 1.5 21 
in 
traces 
28 
12 Pd2(dba)3 (10) PPh3 (40) 6 1.5 40 
in 
traces 
17 
a Yields calculated on the basis of the 1H NMR spectra of the worked-up reaction mixture. 
 
 
 
 
The examinations were extended to the D-galacto 
configured tosylhydrazone 6 (Table 4). The corresponding 
styrene 7a was isolated in good yield (entry 1). The 
substrates bearing both electron-donating (entries 2, 3) and 
electron-withdrawing (entries 4, 5) substituents on the 
aromatic ring could afford the corresponding products 7b-e 
in low to medium yields. There was no clear correlation 
between the yields and the arene substitution pattern (meta 
or para positions, compare entries 2-3 and 4-5). The exo-
galactal 8 and the substituted tosylhydrazone 9 by-products 
were isolated from the reaction mixtures in almost every 
case. 
Some trials were conducted with allyl bromide, 
propargyl bromide and n-butyl bromide to explore the 
possibility of extending the reaction to aliphatic coupling 
partners. However, these experiments gave only very 
complex mixtures from which no discrete product could be 
isolated except for the reaction with allyl bromide which 
furnished the N-allyl tosylhydrazone 10 in a low yield 
(18 %). 
 
 
10 
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Table 4. Pd-catalyzed coupling of tosylhydrazone 6 with benzyl bromides 
 
Entry  R 
R-C6H4-CH2-Br 
(equiv.) 
LiOtBu 
(equiv.) 
Yield (%) 
7 8 9 
1 a H 6 1.5 59 5 nda 
2 b 4-CH3 3 2.2 39 7b nda 
3 c 3-CH3 6 1.5 25 3 7 
4 d 3-Cl 6 1.5 59 3 nda 
5 e 4-Br 6 1.5 31 
in 
traces 
9 
a Not detectable 
b Yields calculated on the basis of the 1H NMR spectra of the worked-up reaction mixture. 
 
 
 
The configuration of the double bonds in compounds 2 
and 7 was E as followed from the vicinal coupling 
constants of the olefinic protons (2: H-1 6.74–6.59 ppm, 
H-2 6.36–6.14 ppm, J1,2 15.9–15.8 Hz; 7: H-1 6.66–6.60 
ppm, H-2 6.12–6.06 ppm, J1,2 15.9–15.8 Hz). This was 
corroborated by a n. O. e. measurement for 2a (Fig. 1) to 
show spatial vicinity of the indicated protons that is 
possible only in the E configuration of the double bond. 
 
Figure 1. Characteristic nuclear Overhauser effects in C-
glucopyranosyl styrene (E)-2a. 
A mechanistic proposal to explain the formation of the 
desired C-glycosyl styrenes and the observed by-products 
is outlined in Scheme 2. The starting tosylhydrazone I is 
deprotonated to lithium-salt V which by acting as a 
nucleophile reacts with the benzyl bromide to give the N-
benzylated tosylhydrazone II. Loss of a toluenesulfinate 
ion from V results in a diazo compound VI. The TsLi can 
react with the benzyl bromide to sulfone XIII observed in 
each reaction and isolated in one case. Diazo compound VI 
on loss of nitrogen gives carbene VII which can undergo 
an intramolecular C-H insertion to give the exo-glycal III. 
Alternatively, VII may enter the catalytic cycle by reacting 
with a benzylpalladium complex XII (formed in the usual 
way by oxidative addition of the benzyl bromide to a Pd(0) 
complex XI) to yield VIII. On the other hand, direct 
formation of VIII is also possible from VI. Intermediate 
VIII may also result in III by a H-shift, thereby providing 
an alternative route to the formation of the exo-glycal by-
product III. Whether III is formed from VII or VIII 
cannot be proven on the basis of the present data, probably 
both routes may be operative. Rearrangement of VIII to 
IX is followed by a β-hydride elimination. From the two 
possibilities loss of Hb is preferred to that of Ha due to the 
formation of the conjugated system resulting in the target 
compounds IV and the Pd-complex X. Loss of HBr from X 
closes the catalytic cycle. 
This complex system of reactions may account for the 
medium yields of the target compounds. Since the benzyl 
bromide reaction partner can participate in two competing 
transformations toward II and XIII besides XII, even its 
relatively high proportion does not lead to high 
conversions. On the other hand, the essential carbene 
intermediate VII is also subject of an intramolecular (to 
III) and an intermolecular (to VIII) reaction, and 
monomolecular transformations used to be faster than 
bimolecular ones. In the light of these competing reaction 
pathways the obtained yields of IV can be considered as 
satisfactory.  
Taking into account that the starting anhydro-aldose 
tosylhydrazones of several configurations are available 
from a free aldose in 3-4 well established steps which 
generally need no chromatographic purification, except in 
some cases for the tosylhydrazone itself, this method gives 
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the target C-glycosyl styrene type compounds in a 
remarkably short reaction sequence. 
 
 
Scheme 2. Mechanistic proposal for the coupling of C-(β-D-glycopyranosyl)formaldehyde tosylhydrazones with benzyl 
bromides and the formation of by-products.
Conclusion 
Pd-Catalyzed cross-couplings of anhydro-aldose 
tosylhydrazones and benzyl bromides give C-
glycopyranosyl styrenes as the main products with 
unavoidable formation of exo-glycals and other by-
products of nucleophilic substitution. The yields of the 
transformations vary between 10-59 %, nevertheless, this 
synthetic route represents a significantly shorter sequence 
to the target compounds from a free aldose in comparison 
to the known methods. 
Experimental Section 
General methods 
Optical rotations were determined with a Perkin–Elmer 
241 polarimeter at room temperature. NMR spectra were 
recorded with Bruker Avance 250 II (250/63 MHz for 
1H/13C), Bruker Avance 300 III (300/75 MHz for 1H/13C), 
Bruker 360 AM Avance (360/90 MHz for 1H/13C) or 
Bruker DRX 400 (400/100 MHz for 1H/13C) spectrometers. 
Chemical shifts are referenced to TMS as the internal 
reference (1H), or to the residual solvent signals (1H, 13C). 
The assignments of the 1H and 13C NMR signals of 
compounds 2, 4, 7, 9 were performed by their COSY 
(2a,d,k, 4b,d, 7a,e, 9e), HSQC (2a,d,k, 4b,d, 7a,e, 9e) and 
HMBC (2a,d,k, 4b,d, 7a,e, 9e) spectra. Mass spectra were 
obtained by an Agilent GC 7890A / MS 5975C or by an 
Agilent HP GC / MS 5890 / 5973 instrument (EI, 70 eV) 
by GC inlet or by a MX-1321 and Finnigan MAT 95 XP 
(Thermo Electron Corp., San Jose, CA, USA) instruments 
(EI, 70 eV) by direct inlet or by an Agilent 1969A Time-
of-Flight or a maXis II UHR ESI-QTOF MS instrument 
(Bruker) operated in positive ion ESI mode. TLC was 
performed on DCAlurolle Kieselgel 60 F254 (Merck). 
TLC plates were visualized under UV light, and by gentle 
heating. For column chromatography Kieselgel 60 (Merck, 
particle size (0.063–0.200 mm) or Al2O3 neutral (Across 
Organics, particle size: (0.050–0.200 mm, 60A) was 
applied. 1,4-Dioxane was distilled from sodium 
benzophenone ketyl and stored over sodium wires. 
General procedure for the synthesis of -(C-2,3,4,6-
tetra-O-acyl-β-D-glycopyranosyl)styrenes (2, 7) 
A (bromomethyl)benzene (3 or 6 mmol, specified with the 
particular compounds), LiOtBu base (2.2 or 1.5 mmol, 
specified with the particular compounds), P(2-furyl)3 
ligand (20 mol%) and Pd2(dba)3 catalyst (2.5 mol%) were 
added to abs. 1,4-dioxane (8 mL). The suspension was 
stirred and heated to 70 °C (bath temp) under an inert (Ar, 
N2) atmosphere and then a solution of tosylhydrazone (1 or 
6 (1 mmol)) in abs. 1,4-dioxane (15 mL) was added 
dropwise in 20 min. When TLC (1:2 EtOAc–hexane or 1:2 
EtOAc–heptane; 1:1 EtOAc–hexane or 1:1 EtOAc–
heptane) indicated complete consumption of the starting 
compound (2.5 h‒22 h), the mixture was cooled and the 
insoluble material filtered off through a pad of celite and 
washed thoroughly with abs. 1,4-dioxane (3 × 20 mL). The 
solvent was removed under reduced pressure, and the 
residue was purified by column chromatography (neutral 
Al2O3) with eluents indicated for the particular compounds 
to give -(C-2,3,4,6-tetra-O-acyl-β-D-glycopyranosyl) 
styrenes. 
(E)-3,7-Anhydro-4,5,6,8-tetra-O-benzoyl-1,2-dideoxy-1-
phenyl-D-glycero-D-gulo-oct-1-enitol ((E)--(C-2,3,4,6-
tetra-O-benzoyl-β-D-glucopyranosyl)styrene) (2a) 
Prepared from tosylhydrazone 1 (0.20 g, 0.26 mmol), 
(bromomethyl)benzene (6 equiv., 0.18 mL, 0.26 g, 1.54 
mmol) and LiOtBu (1.5 equiv., 0.03 g, 0.39 mmol) 
according to General procedure (4h). Purified by column 
chromatography (1:8 EtOAc–heptane) to yield 85 mg 
(48 %) of 2a as a white amorphous product. Rf: 0.39 (1:2 
EtOAc–hexane); [α]D –31 (c 0.65, CHCl3). 1H NMR (400 
MHz, CDCl3) δ 8.14–7.68 (8H, m, aromatics), 7.64–7.06 
(17H, m, aromatics), 6.69 (1H, d, J1,2 15.9 Hz, H-1), 6.20 
(1H, dd, J2,3 7.3 Hz, H-2), 5.98 (1H, pseudo t, J5,6 9.5 Hz, 
H-5), 5.76 (1H, pseudo t, J6,7 9.7 Hz, H-6), 5.54 (1H, 
pseudo t, J4,5 9.8 Hz, H-4), 4.67 (1H, dd, J8a,8b 12.3 Hz, H-
8a), 4.51 (1H, dd, H-8b), 4.39 (1H, dd, J3,4 9.5 Hz, H-3), 
4.21 (1H, ddd, J7,8a 3.1, J7,8b 4.8 Hz, H-7). 13C NMR (100 
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MHz, CDCl3) δ 166.4, 166.1, 165.5, 165.4 (4×CO), 135.2 
(C-1), 136.7–126.1 (aromatics), 124.3 (C-2), 80.0 (C-3), 
76.2 (C-7), 74.3 (C-5), 72.4 (C-4), 69.9 (C-6), 63.5 (C-8). 
HR-ESI-MS positive mode (m/z): calcd. for: 
[M+Na]+=705.2095, found: [M+Na]+=705.2096; C42H34O9 
(682.22).  
2,6-Anhydro-N1-benzyl-3,4,5,7-tetra-O-benzoyl-D-
glycero-D-gulo-heptose tosylhydrazone (N1-benzyl-C-
(2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranosyl)formaldehyde tosylhydrazone) (4a) 
Isolated as a by-product beside 2a from the previous 
reaction mixture by column chromatography (1:8 EtOAc–
hexane) to yield 5 mg (3 %) of 4a as a white amorphous 
product. Rf: 0.10 (1:2 EtOAc–hexane); [α]D –8 (c 0.10, 
CHCl3). 1H NMR (360 MHz, CDCl3) δ 8.13–7.69 (8H, m, 
aromatics), 7.67–7.12 (19H, m, aromatics), 6.93 (2H, d, J 
8.2 Hz, aromatics), 6.82 (1H, d, J1,2 6.6 Hz, H-1), 5.87 (1H, 
pseudo t, J4,5 9.8 Hz, H-4), 5.61 (1H, pseudo t, J5,6 9.7 Hz, 
H-5), 5.33 (1H, pseudo t, J3,4 9.7 Hz, H-3), 4.83 (1H, d, 
JCH2a,CH2b 16.7 Hz, CH2a), 4.70 (1H, d, CH2b), 4.52 (1H, dd, 
J7a,7b 12.2 Hz, H-7a), 4.38 (1H, dd, H-7b), 4.34 (1H, dd, J2,3 
9.7 Hz, H-2), 4.11 (1H, ddd, J6,7a 2.8, J6,7b 4.8 Hz, H-6), 
2.23 (3H, s, CH3). 13C NMR (90 MHz, CDCl3) δ 166.3, 
165.9, 165.4, 165.3 (4×CO), 139.8 (C-1), 144.5–125.5 
(aromatics), 78.8 (C-2), 76.3 (C-6), 73.9 (C-4), 70.9 (C-3), 
69.5 (C-5), 63.3 (C-7), 51.2 (CH2), 21.8 (CH3). HR-ESI-
MS positive mode (m/z): calcd. for: [M+Na]+=889.2402, 
found: [M+Na]+=889.2386; C49H42N2O11S (866.25). 
(E)-3,7-Anhydro-4,5,6,8-tetra-O-benzoyl-1,2-dideoxy-1-
(4-methylphenyl)-D-glycero-D-gulo-oct-1-enitol ((E)--
(C-2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-4-
methylstyrene) (2b) 
Prepared from tosylhydrazone 1 (0.20 g, 0.26 mmol), 1-
bromomethyl-4-methylbenzene (6 equiv., 0.29 g, 1.54 
mmol) and LiOtBu (1.5 equiv., 0,03 g, 0.39 mmol) 
according to General procedure (16h). Purified by column 
chromatography (1:7 EtOAc–hexane) to yield 72 mg 
(40 %) of 2b as a pale yellow amorphous product. Rf: 0.42 
(1:2 EtOAc–hexane); [α]D –20 (c 0.55, CHCl3). 1H NMR 
(400 MHz, CDCl3) δ 8.13–7.76 (8H, m, aromatics), 7.57–
6.91 (16H, m, aromatics), 6.66 (1H, d, J1,2 15.9 Hz, H-1), 
6.14 (1H, dd, J2,3 7.4 Hz, H-2), 5.97 (1H, pseudo t, J5,6 10.1 
Hz, H-5), 5.75 (1H, pseudo t, J6,7 9.8 Hz, H-6), 5.53 (1H, 
pseudo t, J4,5 9.7 Hz, H-4), 4.66 (1H, dd, J8a,8b 12.2 Hz, H-
8a), 4.50 (1H, dd, H-8b), 4.38 (1H, dd, J3,4 9.3 Hz, H-3), 
4.21 (1H, ddd, J7,8a 2.9, J7,8b 4.8 Hz, H-7), 2.28 (3H, s, 
CH3). 13C NMR (100 MHz, CDCl3) δ 166.4, 166.1, 165.4 
(4×CO), 135.2 (C-1), 145.3–125.1 (aromatics), 123.2 (C-2), 
80.2 (C-3), 76.2 (C-7), 74.4 (C-5), 72.4 (C-4), 69.9 (C-6), 
63.5 (C-8), 21.3 (CH3). HR-ESI-MS positive mode (m/z): 
calcd. for: [M+Na]+=719.2252, found: 
[M+Na]+=719.2249; C43H36O9 (696.24). 
2,6-Anhydro-3,4,5,7-tetra-O-benzoyl-N1-(4-
methylbenzyl)-D-glycero-D-gulo-heptose tosylhydrazone 
(N1-4-methylbenzyl-C-(2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranosyl)formaldehyde tosylhydrazone) (4b) 
Isolated as a by-product beside 2b from the previous 
reaction mixture by column chromatography (1:7 EtOAc–
hexane) to yield 25 mg (11 %) of 4b as a white amorphous 
product. Rf: 0.36 (1:2 EtOAc–hexane); [α]D –22 (c 0.60, 
CHCl3). 1H NMR (400 MHz, CDCl3) δ 8.17–7.69 (8H, m, 
aromatics), 7.67–7.12 (14H, m, aromatics), 7.11–6.88 (6H, 
m, aromatics), 6.85 (1H, d, J1,2 6.6 Hz, H-1), 5.87 (1H, 
pseudo t, J4,5 9.8 Hz, H-4), 5.61 (1H, pseudo t, J5,6 9.7 Hz, 
H-5), 5.34 (1H, pseudo t, J3,4 9.7 Hz, H-3), 4.78 (1H, d, 
JCH2a,CH2b 16.5 Hz, CH2a), 4.66 (1H, d, CH2b), 4.52 (1H, dd, 
J7a,7b 12.2 Hz, H-7a), 4.39 (1H, dd, H-7b), 4.34 (1H, dd, J2,3 
10.1 Hz, H-2), 4.11 (1H, ddd, J6,7a 2.5, J6,7b 4.5 Hz, H-6), 
2.27 (3H, s, CH3), 2.23 (3H, s, CH3-Ts). 13C NMR (100 
MHz, CDCl3) δ 166.3, 165.9, 165.4, 165.3 (4×CO), 139.7 
(C-1), 144.0–126.3 (aromatics), 78.8 (C-2), 76.2 (C-6), 
73.9 (C-4), 70.9 (C-3), 69.4 (C-5), 63.9 (C-7), 51.1 (CH2), 
21.8 (CH3-Ts), 21.2 (CH3). HR-ESI-MS positive mode 
(m/z): calcd. for: [M+Na]+=903.2558, found: 
[M+Na]+=903.2566; C50H44N2O11S (880.27). 
 (E)-3,7-Anhydro-4,5,6,8-tetra-O-benzoyl-1,2-dideoxy-
1-(3-methoxyphenyl)-D-glycero-D-gulo-oct-1-enitol ((E)-
-(C-2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-3-
methoxystyrene) (2c) 
Prepared from tosylhydrazone 1 (0.20 g, 0.26 mmol), 1-
bromomethyl-3-methoxybenzene (6 equiv., 0.22 mL, 0.31 
g, 1.54 mmol) and LiOtBu (1.5 equiv., 0.03 g, 0.39 mmol) 
according to General procedure (19h). Purified by column 
chromatography (1:8 EtOAc–hexane) to yield 19 mg 
(10 %) of 2c as a yellow amorphous product. Rf: 0.31 (1:2 
EtOAc–hexane); [α]D –25 (c 0.60, CHCl3). 1H NMR (400 
MHz, CDCl3) δ 8.11–7.78 (8H, m, aromatics), 7.62–7.23 
(12H, m, aromatics), 7.18–7.11 (1H, m, aromatic), 6.99–
6.72 (3H, m, aromatics), 6.66 (1H, d, J1,2 15.9 Hz, H-1), 
6.18 (1H, dd, J2,3 7.3 Hz, H-2), 5.97 (1H, pseudo t, J5,6 9.8 
Hz, H-5), 5.75 (1H, pseudo t, J6,7 9.8 Hz, H-6), 5.53 (1H, 
pseudo t, J4,5 9.5 Hz, H-4), 4.65 (1H, dd, J8a,8b 12.3 Hz, H-
8a), 4.50 (1H, dd, H-8b), 4.39 (1H, dd, J3,4 9.2 Hz, H-3), 
4.21 (1H, ddd, J7,8a 2.8, J7,8b 4.8 Hz, H-7), 3.75 (3H, s, O–
CH3). 13C NMR (100 MHz, CDCl3) δ 166.4, 166.1, 165.4 
(4×CO), 135.0 (C-1), 137.7–110.0 (aromatics), 124.6 (C-2), 
80.0 (C-3), 76.2 (C-7), 74.3 (C-5), 72.4 (C-4), 69.9 (C-6), 
63.5 (C-8), 55.3 (O–CH3). HR-ESI-MS positive mode 
(m/z): calcd. for: [M+Na]+=735.2201, found: 
[M+Na]+=735.2199; C43H36O10 (712.23). 
2,6-Anhydro-3,4,5,7-tetra-O-benzoyl-N1-(3-
methoxybenzyl)-D-glycero-D-gulo-heptose 
tosylhydrazone (N1-3-methoxybenzyl-C-(2,3,4,6-tetra-
O-benzoyl-β-D-glucopyranosyl)formaldehyde 
tosylhydrazone) (4c) 
Isolated as a by-product beside 2c from the previous 
reaction mixture by column chromatography (1:8 EtOAc–
hexane) to yield 72 mg (31 %) of 4c as a yellow 
amorphous product. Rf: 0.23 (1:2 EtOAc–hexane); [α]D –2 
(c 0.45, CHCl3). 1H NMR (400 MHz, CDCl3) δ 8.28–7.69 
(8H, m, aromatics), 7.64–7.04 (16H, m, aromatics), 6.92 
(2H, d, J 8.2 Hz, aromatics), 6.86 (1H, d, J1,2 6.7 Hz, H-1), 
6.83–6.72 (2H, m, aromatics), 5.88 (1H, pseudo t, J4,5 9.7 
Hz, H-4), 5.62 (1H, pseudo t, J5,6 10.0 Hz, H-5), 5.34 (1H, 
pseudo t, J3,4 9.7 Hz, H-3), 4.82 (1H, d, JCH2a,CH2b 16.6 Hz, 
CH2a), 4.64 (1H, d, CH2b), 4.53 (1H, dd, J7a,7b 12.3 Hz, H-
7a), 4.39 (1H, dd, H-7b), 4.34 (1H, dd, J2,3 9.9 Hz, H-2), 
4.12 (1H, ddd, J6,7a 2.4, J6,7b 5.2 Hz, H-6), 3.68 (3H, s, O–
CH3), 2.22 (3H, s, CH3). 13C NMR (90 MHz, CDCl3) δ 
166.3, 165.9, 165.4, 165.3 (4×CO), 140.0 (C-1), 160.4–
111.5 (aromatics), 78.8 (C-2), 76.3 (C-6), 73.8 (C-4), 70.9 
(C-3), 69.4 (C-5), 63.4 (C-7), 55.3 (O–CH3), 51.3 (CH2), 
21.8 (CH3). HR-ESI-MS positive mode (m/z): calcd. for: 
[M+Na]+=919.2507, found: [M+Na]+=919.2508; 
C50H44N2O11S (896.26). 
4-Methylphenyl-3-methoxybenzyl sulfone (5c) 
Isolated as a by-product beside 2c from the previous 
reaction mixture by column chromatography (1:8 EtOAc–
hexane) to yield 40 mg (56 %) of 5c as a yellow 
amorphous product. 1H NMR (360 MHz, CDCl3) δ 7.53 
(2H, d, J 8.2 Hz, Ts), 7.24 (2H, d, J 8.1 Hz, Ts), 7.20–7.10 
(1H, m, aromatic), 6.85 (1H, d, J 7.3 Hz, aromatic), 6.68–
6.58 (2H, m, aromatics), 4.26 (2H, s, CH2), 3.71 (3H, s, O–
CH3), 2.41 (3H, s, CH3). 13C NMR (90 MHz, CDCl3) δ 
140.4–114.5 (aromatics), 63.1 (O–CH3), 55.3 (CH2), 21.7 
(CH3). HR-ESI-MS positive mode (m/z): calcd. for: 
[M+Na]+=299.0712, found: [M+Na]+=299.0710; 
C15H16O3S (276.08). 
(E)-3,7-Anhydro-4,5,6,8-tetra-O-benzoyl-1-(4-
chlorophenyl)-1,2-dideoxy-D-glycero-D-gulo-oct-1-enitol 
((E)--(C-2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-
4-chlorostyrene) (2d) 
Prepared from tosylhydrazone 1 (0.20 g, 0.26 mmol), 1-
bromomethyl-4-chlorobenzene (6 equiv., 0.32 g, 1.54 
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mmol) and LiOtBu (1.5 equiv., 0.03 g, 0.39 mmol) 
according to General procedure (4.5h). Purified by column 
chromatography (1:8 EtOAc–hexane) to yield 74 mg 
(40 %) of 2d as an orange amorphous product. Rf: 0.44 
(1:2 EtOAc–hexane); [α]D –17 (c 0.35, CHCl3). 1H NMR 
(400 MHz, CDCl3) δ 8.19–7.77 (8H, m, aromatics), 7.66–
7.06 (16H, m, aromatics), 6.63 (1H, d, J1,2 15.9 Hz, H-1), 
6.17 (1H, dd, J2,3 7.2 Hz, H-2), 5.98 (1H, pseudo t, J5,6 9.5 
Hz, H-5), 5.75 (1H, pseudo t, J6,7 9.9 Hz, H-6), 5.51 (1H, 
pseudo t, J4,5 9.8 Hz, H-4), 4.67 (1H, dd, J8a,8b 12.3 Hz, H-
8a), 4.50 (1H, dd, H-8b), 4.38 (1H, dd, J3,4 9.5 Hz, H-3), 
4.21 (1H, ddd, J7,8a 2.9, J7,8b 4.8 Hz, H-7). 13C NMR (100 
MHz, CDCl3) δ 166.3, 166.1, 165.5, 165.4 (4×CO), 134.6 
(C-1), 136.5–126.1 (aromatics), 125.0 (C-2), 79.9 (C-3), 
76.2 (C-7), 74.2 (C-5), 72.4 (C-4), 69.8 (C-6), 63.4 (C-8). 
HR-ESI-MS positive mode (m/z): calcd. for: 
[M+Na]+=739.1705, found: [M+Na]+=739.1705; 
C42H33ClO9 (716.18). 
2,6-Anhydro-3,4,5,7-tetra-O-benzoyl-N1-(4-
chlorobenzyl)-D-glycero-D-gulo-heptose tosylhydrazone 
(N1-4-chlorobenzyl-C-(2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranosyl)formaldehyde tosylhydrazone) (4d) 
Isolated as a by-product beside 2d from the previous 
reaction mixture by column chromatography (1:8 EtOAc–
hexane) to yield 33 mg (14 %) of 4d as a yellow 
amorphous product. Rf: 0.30 (1:2 EtOAc–hexane); [α]D –
17 (c 0.30, CHCl3). 1H NMR (400 MHz, CDCl3) δ 8.12–
7.67 (8H, m, aromatics), 7.65–7.11 (14H, m, aromatics), 
7.09–6.89 (6H, m, aromatics), 6.80 (1H, d, J1,2 6.6 Hz, H-
1), 5.88 (1H, pseudo t, J4,5 9.6 Hz, H-4), 5.62 (1H, pseudo t, 
J5,6 10.0 Hz, H-5), 5.34 (1H, pseudo t, J3,4 9.8 Hz, H-3), 
4.75 (1H, d, JCH2a,CH2b 16.8 Hz, CH2a), 4.68 (1H, d, CH2b), 
4.54 (1H, dd, J7a,7b 12.4 Hz, H-7a), 4.40 (1H, dd, H-7b), 
4.34 (1H, dd, J2,3 9.9 Hz, H-2), 4.13 (1H, ddd, J6,7a 2.8, J6,7b 
4.9 Hz, H-6), 2.23 (3H, s, CH3). 13C NMR (100 MHz, 
CDCl3) δ 166.2, 165.9, 165.4, 165.3 (4×CO), 139.9 (C-1), 
145.3–127.6 (aromatics), 78.7 (C-2), 76.3 (C-6), 73.7 (C-4), 
70.8 (C-3), 69.4 (C-5), 63.3 (C-7), 50.5 (CH2), 21.8 (CH3). 
HR-ESI-MS positive mode (m/z): calcd. for: 
[M+Na]+=923.2012, found: [M+Na]+=923.2016; 
C49H41ClN2O11S (900.21). 
(E)-3,7-Anhydro-4,5,6,8-tetra-O-benzoyl-1-(3-
chlorophenyl)-1,2-dideoxy-D-glycero-D-gulo-oct-1-enitol 
((E)--(C-2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-
3-chlorostyrene) (2e) 
Prepared from tosylhydrazone 1 (0.20 g, 0.26 mmol), 1-
bromomethyl-3-chlorobenzene (6 equiv., 0.20 mL, 0.32 g, 
1.54 mmol) and LiOtBu (1.5 equiv., 0.03 g, 0.39 mmol) 
according to General procedure (4.5h). Purified by column 
chromatography (1:8 EtOAc–heptane) to yield 78 mg 
(42 %) of 2e as a yellow amorphous product. Rf: 0.39 (1:2 
EtOAc–hexane); [α]D –35 (c 0.70, CHCl3). 1H NMR (250 
MHz, CDCl3) δ 8.12–7.74 (8H, m, aromatics), 7.63–6.92 
(16H, m, aromatics), 6.60 (1H, d, J1,2 15.9 Hz, H-1), 6.18 
(1H, dd, J2,3 7.0 Hz, H-2), 5.97 (1H, pseudo t, J5,6 9.8 Hz, 
H-5), 5.73 (1H, pseudo t, J6,7 9.8 Hz, H-6), 5.50 (1H, 
pseudo t, 1H, J4,5 9.5 Hz, H-4), 4.65 (1H, dd, J8a,8b 12.2 Hz, 
H-8a), 4.48 (1H, dd, H-8b), 4.36 (1H, dd, J3,4 9.2 Hz, H-3), 
4.19 (1H, ddd, J7,8a 2.9, J7,8b 5.0 Hz, H-7). 13C NMR (63 
MHz, CDCl3) δ 166.3, 166.1, 165.4, 165.3 (4×CO), 133.5 
(C-1), 145.5–125.2 (aromatics), 124.9 (C-2), 79.6 (C-3), 
76.2 (C-7), 74.2 (C-5), 72.4 (C-4), 69.8 (C-6), 63.4 (C-8). 
HR-ESI-MS positive mode (m/z): calcd. for: 
[M+Na]+=739.1705, found: [M+Na]+=739.1710; 
C42H33ClO9 (716.18). 
(E)-3,7-Anhydro-4,5,6,8-tetra-O-benzoyl-1-(4-
bromophenyl)-1,2-dideoxy-D-glycero-D-gulo-oct-1-enitol 
((E)-4-bromo--(C-2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranosyl)styrene) (2f) 
Prepared from tosylhydrazone 1 (0.20 g, 0.26 mmol), 1-
bromomethyl-4-bromobenzene (6 equiv., 0.39 g, 1.54 
mmol) and LiOtBu (1.5 equiv., 0.03 g, 0.39 mmol) 
according to General procedure (4h). Purified by column 
chromatography (1:8 EtOAc–heptane) to yield 107 mg 
(54 %) of 2f as a yellow amorphous product. Rf: 0.36 (1:2 
EtOAc–hexane); [α]D –49 (c 2.10, CHCl3). 1H NMR (300 
MHz, CDCl3) δ 8.09–7.75 (8H, m, aromatics), 7.58–7.16 
(14H, m, aromatics), 7.09 (2H, d, J 8.5 Hz, aromatics), 
6.59 (1H, d, J1,2 15.9 Hz, H-1), 6.16 (1H, dd, J2,3 7.2 Hz, 
H-2) 5.96 (1H, pseudo t, J5,6 9.6 Hz, H-5), 5.73 (1H, 
pseudo t, J6,7 9.9 Hz, H-6), 5.49 (1H, pseudo t, J4,5 9.6 Hz, 
H-4), 4.65 (1H, dd, J8a,8b 12.2 Hz, H-8a), 4.48 (1H, dd, H-
8b), 4.36 (1H, dd, J3,4 9.2 Hz, H-3), 4.19 (1H, ddd, J7,8a 2.9, 
J7,8b 4.8 Hz, H-7). 13C NMR (63 MHz, CDCl3) δ 166.3, 
166.1, 165.5, 165.4 (4×CO), 133.7 (C-1), 135.5–122.0 
(aromatics), 125.1 (C-2), 79.8 (C-3), 76.2 (C-7), 74.2 (C-5), 
72.4 (C-4), 69.8 (C-6), 63.4 (C-8). HR-ESI-MS positive 
mode (m/z): calcd. for: [M+Na]+=783.1200, found: 
[M+Na]+=783.1219; C42H33BrO9 (760.13). 
(E)-3,7-Anhydro-4,5,6,8-tetra-O-benzoyl-1-(3-
bromophenyl)-1,2-dideoxy-D-glycero-D-gulo-oct-1-enitol 
((E)-3-bromo--(C-2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranosyl)styrene) (2g) 
Prepared from tosylhydrazone 1 (0.20 g, 0.26 mmol), 1-
bromomethyl-3-bromobenzene (6 equiv., 0.39 g, 1.54 
mmol) and LiOtBu (1.5 equiv., 0.03 g, 0.39 mmol) 
according to General procedure (20h). Purified by column 
chromatography (1:7 EtOAc–hexane) to yield 63 mg 
(32 %) of 2g as a yellow amorphous product. Rf: 0.39 (1:2 
EtOAc–hexane); [α]D –20 (c 0.45, CHCl3). 1H NMR (400 
MHz, CDCl3) δ 8.13–7.78 (8H, m, aromatics), 7.62–6.99 
(16H, m, aromatics), 6.60 (1H, d, J1,2 15.9 Hz, H-1), 6.19 
(1H, dd, J2,3 7.0 Hz, H-2), 5.99 (1H, pseudo t, J5,6 9.5 Hz, 
H-5), 5.76 (1H, pseudo t, J6,7 9.8 Hz, H-6), 5.52 (1H, 
pseudo t, J4,5 9.8 Hz, H-4), 4.67 (1H, dd, J8a,8b 12.3 Hz, H-
8a), 4.51 (1H, dd, H-8b), 4.40 (1H, dd, J3,4 9.2 Hz, H-3), 
4.23 (1H, ddd, J7,8a 2.3, J7,8b 4.7 Hz, H-7). 13C NMR (90 
MHz, CDCl3) δ 166.3, 166.0, 165.4, 165.3 (4×CO), 133.8 
(C-1), 145.3–122.4 (aromatics), 125.3 (C-2), 79.6 (C-3), 
76.2 (C-7), 74.3 (C-5), 72.4 (C-4), 69.8 (C-6), 63.4 (C-8). 
HR-ESI-MS positive mode (m/z): calcd. for: 
[M+Na]+=783.1200, found: [M+Na]+=783.1211; 
C42H33BrO9 (760.13). 
2,6-Anhydro-3,4,5,7-tetra-O-benzoyl-N1-(3-
bromobenzyl)-D-glycero-D-gulo-heptose tosylhydrazone 
(N1-3-bromobenzyl-C-(2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranosyl)formaldehyde tosylhydrazone) (4g) 
Isolated as a by-product beside 2g from the previous 
reaction mixture by column chromatography (1:7 EtOAc–
hexane) to yield 13 mg (5 %) of 4g as a white amorphous 
product. Rf: 0.31 (1:2 EtOAc–hexane); [α]D –7 (c 0.29, 
CHCl3). 1H NMR (400 MHz, CDCl3) δ 8.12–7.71 (8H, m, 
aromatics), 7.67–7.19 (16H, m, aromatics), 7.18–6.88 (4H, 
m, aromatics), 6.82 (1H, d, J1,2 6.6 Hz, H-1), 5.89 (1H, 
pseudo t, J4,5 9.9 Hz, H-4), 5.63 (1H, pseudo t, J5,6 9.9 Hz, 
H-5), 5.34 (1H, pseudo t, J3,4 9.6 Hz, H-3), 4.80 (1H, d, 
JCH2a,CH2b 16.8 Hz, CH2a), 4.65 (1H, d, CH2b), 4.54 (1H, dd, 
J7a,7b 12.3 Hz, H-7a), 4.40 (1H, dd, H-7b), 4.34 (1H, dd, J2,3 
9.9 Hz, H-2), 4.13 (1H, ddd, J6,7a 2.8, J6,7b 5.1 Hz, H-6), 
2.22 (3H, s, CH3). 13C NMR (100 MHz, CDCl3) δ 166.4, 
165.9, 165.5, 165.3 (4×CO), 133.3 (C-1), 144.5–123.1 
(aromatics), 78.8 (C-2), 76.3 (C-6), 73.7 (C-4), 71.0 (C-3), 
69.4 (C-5), 63.3 (C-7), 50.6 (CH2), 21.8 (CH3). HR-ESI-
MS positive mode (m/z): calcd. for: [M+Na]+=967.1507, 
found: [M+Na]+=967.1519; C49H41BrN2O11S (944.16). 
(E)-3,7-Anhydro-4,5,6,8-tetra-O-benzoyl-1-(2-
bromophenyl)-1,2-dideoxy-D-glycero-D-gulo-oct-1-enitol 
((E)-2-bromo--(C-2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranosyl)styrene) (2h) 
Prepared from tosylhydrazone 1 (0.20 g, 0.26 mmol), 1-
bromomethyl-2-bromobenzene (6 equiv., 0.39 g, 1.54 
mmol) and LiOtBu (1.5 equiv., 0.03 g, 0.39 mmol) 
according to General procedure (21h). Purified by column 
chromatography (1:7 EtOAc–hexane) to yield 71 mg 
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(36 %) of 2h as pale yellow amorphous product. Rf: 0.43 
(1:2 EtOAc–hexane); [α]D –13 (c 0.40, CHCl3). 1H NMR 
(360 MHz, CDCl3) δ 8.23–7.73 (8H, m, aromatics), 7.68–
7.13 (15H, m, aromatics), 7.11–7.04 (1H, m, aromatic), 
7.01 (1H, d, J1,2 15.8 Hz, H-1), 6.13 (1H, dd, J2,3 7.3 Hz, 
H-2) 5.99 (1H, pseudo t, J5,6 9.9 Hz, H-5), 5.75 (1H, 
pseudo t, J6,7 9.9 Hz, H-6), 5.53 (1H, pseudo t, J4,5 9.6 Hz, 
H-3), 4.68 (1H, dd, J8a,8b 12.2 Hz, H-8a), 4.50 (1H, dd, H-
8b), 4.45 (1H, dd, J3,4 9.2 Hz, H-3), 4.23 (1H, ddd, J7,8a 2.8, 
J7,8b 4.9 Hz, H-5). 13C NMR (100 MHz, CDCl3) δ 166.4, 
166.1, 165.6, 165.4 (4×CO), 133.8 (C-1), 136.4–123.4 
(aromatics), 127.3 (C-2), 79.9 (C-3), 76.2 (C-7), 74.3 (C-5), 
72.3 (C-4), 69.9 (C-6), 63.4 (C-8). HR-ESI-MS positive 
mode (m/z): calcd. for: [M+Na]+=783.1200, found: 
[M+Na]+=783.1211; C42H33BrO9 (760.13). 
2,6-Anhydro-3,4,5,7-tetra-O-benzoyl-N1-(2-
bromobenzyl)-D-glycero-D-gulo-heptose tosylhydrazone 
(N1-2-bromobenzyl-C-(2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranosyl)formaldehyde tosylhydrazone) (4h) 
Isolated as a by-product beside 2h from the previous 
reaction mixture by column chromatography (1:7 EtOAc–
hexane) to yield 4 mg (2 %) of 4h as a white amorphous 
product. Rf: 0.27 (1:2 EtOAc–hexane); [α]D +3 (c 0.60, 
CHCl3).1H NMR (400 MHz, CDCl3) δ 8.15–7.70 (8H, m, 
aromatics), 7.69–7.19 (14H, m, aromatics), 7.15–6.89 (6H, 
m, aromatics), 6.84 (1H, d, J1,2 6.6 Hz, H-1), 5.86 (1H, 
pseudo t, J4,5 9.7 Hz, H-4), 5.61 (1H, pseudo t, J5,6 9.8 Hz, 
H-5), 5.34 (1H, pseudo t, J3,4 9.7 Hz, H-3), 4.78 (1H, d, 
JCH2a,CH2b 16.5 Hz, CH2a), 4.65 (1H, d, CH2b), 4.52 (1H, dd, 
J7a,7b 12.3 Hz, H-7a), 4.40 (1H, dd, H-7b), 4.34 (1H, dd, J2,3 
9.9 Hz, H-2), 4.11 (1H, ddd, J6,7a 2.8, J6,7b 5.0 Hz, H-6), 
2.23 (3H, s, CH3). 13C NMR (100 MHz, CDCl3) δ 166.3, 
165.9, 165.3 (4×CO), 139.5 (C-1), 144.8–120.7 
(aromatics), 78.7 (C-2), 76.3 (C-6), 73.9 (C-4), 70.8 (C-3), 
69.4 (C-5), 63.3 (C-7), 51.1 (CH2), 21.8 (CH3). HR-ESI-
MS positive mode (m/z): calcd. for: [M+Na]+=967.1507, 
found: [M+Na]+=967.1506; C49H41BrN2O11S (944.16). 
3,7-Anhydro-4,5,6,8-tetra-O-benzoyl-1,2-dideoxy-1-(4-
nitrophenyl)-D-glycero-D-gulo-oct-1-enitol (-(C-
2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-4-
nitrostyrene) (2i) 
Prepared from tosylhydrazone 1 (0.20 g, 0.26 mmol), 1-
bromomethyl-4-nitrobenzene (6 equiv., 0.33 g, 1.54 mmol) 
and LiOtBu (1.5 equiv., 0.03 g, 0.39 mmol) according to 
General procedure (19h). Purified by column 
chromatography (1:7 EtOAc–hexane) to yield 74 mg 
(40 %) (E/Z = 1:1) of 2i as an orange amorphous product. 
Rf: 0.34 (1:2 EtOAc–hexane). E isomer: 1H NMR (400 
MHz, CDCl3) δ 8.32–7.68 (8H, m, aromatics), 7.66–7.13 
(16H, m, aromatics), 6.74 (1H, d, J1,2 15.9 Hz, H-1), 6.36 
(1H, dd, J2,3 6.7 Hz, H-2), 6.00 (1H, pseudo t, J5,6 10.0 Hz, 
H-5), 5.76 (1H, pseudo t, J6,7 9.9 Hz, H-6), 5.51 (1H, 
pseudo t, J4,5 9.6 Hz, H-4), 4.69 (1H, dd, J8a,8b 12.4 Hz, H-
8a), 4.50 (1H, dd, H-8b), 4.43 (1H, dd, J3,4 9.9 Hz, H-3), 
4.22 (1H, ddd, J7,8a 2.7, J7,8b 5.0 Hz, H-7). 13C NMR (100 
MHz, CDCl3) δ 166.3, 166.0, 165.5, 165.4 (4×CO), 147.6–
110.7 (C-1, C-2, aromatics), 79.3 (C-3), 76.3 (C-7), 73.9 
(C-5), 72.4 (C-4), 69.7 (C-6), 63.3 (C-8). Z isomer: 1H 
NMR (400 MHz, CDCl3) δ 8.32–7.68 (8H, m, aromatics), 
7.66–7.13 (16H, m, aromatics), 6.81 (1H, d, J1,2 11.6 Hz, 
H-1), 6.01 (1H, dd, J2,3 2.5 Hz, H-2), 5.89 (1H, pseudo t, 
J5,6 9.6 Hz, H-5), 5.69 (1H, pseudo t, J6,7 9.9 Hz, H-6), 5.64 
(1H, pseudo t, J4,5 9.7 Hz, H-4), 4.66 (1H, dd, J7,8a 2.5, 
J8a,8b 12.6 Hz, H-8a), 4.56–4.45 (2H, m, H-3, H-8b), 4.27–
4.15 (1H, m, H-7). 13C NMR (100 MHz, CDCl3) δ 166.3, 
166.0, 165.4 (4×CO), 147.6–110.7 (C-1, C-2, aromatics), 
76.4 (C-7), 74.5 (C-3), 74.1 (C-5), 72.5 (C-4), 69.8 (C-6), 
63.7 (C-8). HR-ESI-MS positive mode (m/z): calcd. for: 
[M+Na]+=750.1946, found: [M+Na]+=750.1939; 
C42H33NO11 (727.21). 
2,6-Anhydro-3,4,5,7-tetra-O-benzoyl-N1-(4-
nitrobenzyl)-D-glycero-D-gulo-heptose tosylhydrazone 
(N1-4-nitrobenzyl-C-(2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranosyl)formaldehyde tosylhydrazone) (4i) 
Isolated as a by-product beside 2i from the previous 
reaction mixture by column chromatography (1:8 EtOAc–
hexane) to yield 39 mg (16 %) of 4i as a yellow amorphous 
product. Rf: 0.23 (1:2 EtOAc–hexane); [α]D –4 (c 0.60, 
CHCl3). 1H NMR (400 MHz, CDCl3) δ 8.23–7.61 (12H, m, 
aromatics), 7.60–7.20 (14H, m, aromatics), 6.98 (2H, d, J 
8.3 Hz, aromatics), 6.75 (1H, d, J1,2 6.6 Hz, H-1), 5.88 (1H, 
pseudo t, J4,5 9.7 Hz, H-4), 5.63 (1H, pseudo t, J5,6 9.6 Hz, 
H-5), 5.31 (1H, pseudo t, J3,4 9.6 Hz, H-3), 4.85 (2H,s, 
CH2), 4.56 (1H, dd, J7a,7b 12.4 Hz, H-7a), 4.39 (1H, dd, H-
7b), 4.35 (1H, dd, J2,3 9.9 Hz, H-2), 4.13 (1H, ddd, J6,7a 2.6, 
J6,7b 5.3 Hz, H-6), 2.25 (3H, s, CH3). 13C NMR (100 MHz, 
CDCl3) δ 166.2, 165.9, 165.5, 165.3 (4×CO), 140.4 (C-1), 
147.8–123.5 (aromatics), 78.6 (C-2), 76.4 (C-6), 73.6 (C-4), 
70.9 (C-3), 69.3 (C-5), 63.1 (C-7), 50.5 (CH2), 21.8 (CH3). 
HR-ESI-MS positive mode (m/z): calcd. for: 
[M+Na]+=934.2252, found: [M+Na]+=934.2245; 
C49H41N3O13S (911.24). 
(E)-3,7-Anhydro-4,5,6,8-tetra-O-benzoyl-1-(4-
cyanophenyl)-1,2-dideoxy-D-glycero-D-gulo-oct-1-enitol 
((E)-4-cyano--(C-2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranosyl)styrene) (2j) 
Prepared from tosylhydrazone 1 (0.20 g, 0.26 mmol), 4-
bromomethyl benzonitrile (6 equiv., 0.30 g, 1.54 mmol), 
LiOtBu (1.5 equiv., 0.03 g, 0.39 mmol), P(2-furyl)3 (4 
equiv., 0.24 g, 1.02 mmol) and Pd2(dba)3 (50 mol%, 0.12 g, 
0.13 mmol) according to General procedure (20.5h). 
Purified by column chromatography (1:8 EtOAc–hexane) 
to yield 100 mg (55 %) of 2j as a pale yellow amorphous 
product. Rf: 0.26 (1:2 EtOAc–hexane); [α]D –45 (c 1.75, 
CHCl3).1H NMR (400 MHz, CDCl3) δ 8.16–7.74 (8H, m, 
aromatics), 7.62–7.18 (16H, m, aromatics), 6.69 (1H, d, 
J1,2 15.9 Hz, H-1), 6.31 (1H, dd, J2,3 6.8 Hz, H-2), 6.00 (1H, 
pseudo t, J5,6 9.6 Hz, H-5), 5.76 (1H, pseudo t, J6,7 9.9 Hz, 
H-6), 5.51 (1H, pseudo t, J4,5 9.7 Hz, H-4), 4.69 (1H, dd, 
J8a,8b 12.3 Hz, H-8a), 4.51 (1H, dd, H-8b), 4.42 (1H, dd, J3,4 
9.6 Hz, H-3), 4.23 (1H, ddd, J7,8a 2.8, J7,8b 4.8 Hz, H-7). 
13C NMR (100 MHz, CDCl3) δ 166.3, 166.0, 165.5, 165.3 
(4×CO), 132.6 (C-1), 140.7–118.7 (aromatics), 128.2 (C-2), 
111.6 (CN), 79.3 (C-3), 76.3 (C-7), 74.1 (C-5), 72.4 (C-4), 
69.7 (C-6), 63.3 (C-8). HR-ESI-MS positive mode (m/z): 
calcd. for: [M+Na]+=730.2048, found: 
[M+Na]+=730.2038; C43H33NO9 (707.22). 
2,6-Anhydro-3,4,5,7-tetra-O-benzoyl-N1-(4-
cyanobenzyl)-D-glycero-D-gulo-heptose tosylhydrazone 
(N1-4-cyanobenzyl-C-(2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranosyl)formaldehyde tosylhydrazone) (4j) 
Isolated as a by-product beside 2j from the previous 
reaction mixture by column chromatography (1:8 EtOAc–
hexane) to yield 15 mg (7 %) of 4j as a pale yellow 
amorphous product. Rf: 0.14 (1:2 EtOAc–hexane); [α]D –9 
(c 1.40, CHCl3). 1H NMR (400 MHz, CDCl3) δ 8.16–7.70 
(8H, m, aromatics), 7.68–7.13 (18H, m, aromatics), 6.97 
(2H, d, J 8.2 Hz, aromatics), 6.75 (1H, d, J1,2 6.6 Hz, H-1), 
5.89 (1H, pseudo t, J4,5 9.5 Hz, H-4), 5.63 (1H, pseudo t, 
J5,6 10.0 Hz, H-5), 5.32 (1H, pseudo t, J3,4 9.8 Hz, H-3), 
4.80 (2H, s, CH2), 4.56 (1H, dd, J7a,7b 12.3 Hz, H-7a), 4.39 
(1H, dd, H-7b), 4.35 (1H, dd, J2,3 9.8 Hz, H-2), 4.14 (1H, 
ddd, J6,7a 2.7, J6,7b 4.9 Hz, H-6), 2.24 (3H, s, CH3). 13C 
NMR (100 MHz, CDCl3) δ 166.2, 165.8, 165.4, 165.2 
(4×CO), 140.2 (C-1), 145.5–118.2 (aromatics), 111.9 (CN), 
78.5 (C-2), 76.3 (C-6), 73.6 (C-4), 70.8 (C-3), 69.3 (C-5), 
63.1 (C-7), 50.6 (CH2), 21.8 (CH3). HR-ESI-MS positive 
mode (m/z): calcd. for: [M+Na]+=914.2354, found: 
[M+Na]+=914.2358; C50H41N3O11S (891.25). 
(E)-4,5,6,8-Tetra-O-acetyl-3,7-anhydro-1,2-dideoxy-1-
phenyl-D-glycero-L-manno-oct-1-enitol ((E)--(C-
2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)styrene) 
(7a) 
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Prepared from tosylhydrazone 6 (0.20 g, 0.38 mmol), 
(bromomethyl)benzene (6 equiv., 0.27 mL, 0.39 g, 2.27 
mmol) and LiOtBu (1.5 equiv., 0.05 g, 0.57 mmol) 
according to General procedure (4h). Purified by column 
chromatography (1:2 EtOAc–heptane) to yield 98 mg 
(59 %) of 7a as an orange amorphous product. Rf: 0.42 
(1:1 EtOAc–hexane); [α]D –3 (c 0.55, CHCl3). 1H NMR 
(400 MHz, CDCl3) δ 7.40–7.14 (5H, m, aromatics), 6.66 
(1H, d, J1,2 15.9 Hz, H-1), 6.11 (1H, dd, J2,3 7.8 Hz, H-2), 
5.48 (1H, dd, J6,7 0.9 Hz, H-6), 5.25 (1H, pseudo t, J4,5 10.2 
Hz, H-4), 5.13 (1H, dd, J5,6 3.4 Hz, H-5), 4.17 (1H, dd, 
J8a,8b 13.5 Hz, H-8a), 4.13 (1H, dd, H-8b), 4.02 (1H, dd, J3,4 
9.8 Hz, H-3), 4.00 (1H, ddd, J7,8a 6.6, J7,8b 6.6 Hz, H-7), 
2.18, 2.05, 2.00, 1.95 (12H, 4s, 4×CH3). 13C NMR (100 
MHz, CDCl3) δ 170.5, 170.4, 170.3, 169.8 (4×CO), 135.1 
(C-1), 136.0–111.0 (aromatics), 124.3 (C-2), 80.3 (C-3), 
74.1 (C-7), 71.8 (C-5), 68.8 (C-4), 67.8 (C-6), 61.8 (C-8), 
20.8, 20.7 (4×CH3). HR-ESI-MS positive mode (m/z): 
calcd. for: [M+Na]+=434.1469, found: 
[M+Na]+=457.1468; C22H26O9 (434.16). NMR spectra are 
identical with those reported.[6] 
(E)-4,5,6,8-Tetra-O-acetyl-3,7-anhydro-1,2-dideoxy-1-
(4-methylphenyl)-D-glycero-L-manno-oct-1-enitol ((E)-
-(C-2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-4-
methylstyrene) (7b) 
Prepared from tosylhydrazone 6 (0.10 g, 0.19 mmol), 1-
bromomethyl-4-methylbenzene (3 equiv., 0.11 g, 0.57 
mmol) and LiOtBu (2.2 equiv., 0.03 g, 0.42 mmol) 
according to General procedure (2.5h). Purified by column 
chromatography (1:5 EtOAc–heptane) to yield 33 mg 
(39 %) of 7b as an orange amorphous product. Rf: 0.45 
(1:1 EtOAc–hexane); [α]D –7 (c 0.70, CHCl3). 1H NMR 
(360 MHz, CDCl3) δ 7.37–6.98 (4H, m, aromatics), 6.62 
(1H, d, J1,2 15.8 Hz, H-1), 6.06 (1H, dd, J2,3 7.9 Hz, H-2), 
5.48 (1H, dd, J6,7 0.8 Hz, H-6), 5.24 (1H, pseudo t, J4,5 10.2 
Hz, H-4), 5.11 (1H, dd, J5,6 3.4 Hz, H-5), 4.14 (2H, m, H-
8a, H-8b), 4.03–3.93 (2H, m, H-3, H-7), 2.34 (3H, s, CH3), 
2.18, 2.06, 2.00, 1.95 (12H, 4s, 4×CH3). 13C NMR (75 
MHz, CDCl3) δ 170.7, 170.5, 170.4, 169.9 (4×CO), 135.3 
(C-1), 138.5–125.2 (aromatics), 123.4 (C-2), 80.6 (C-3), 
74.3 (C-7), 71.9 (C-5), 68.9 (C-4), 67.9 (C-6), 62.0 (C-8), 
21.4 (CH3), 20.9, 20.8 (4×CH3). HR-ESI-MS positive 
mode (m/z): calcd. for: [M+Na]+=471.1626, found: 
[M+Na]+=471.1626; C23H28O9 (448.17). 
 (E)-4,5,6,8-Tetra-O-acetyl-3,7-anhydro-1,2-dideoxy-1-
(3-methylphenyl)-D-glycero-L-manno-oct-1-enitol ((E)-
-(C-2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-3-
methylstyrene) (7c) 
Prepared from tosylhydrazone 6 (0.20 g, 0.38 mmol), 1-
bromomethyl-3-methylbenzene (6 equiv., 0.31 mL, 0.42 g, 
2.27 mmol) and LiOtBu (1.5 equiv., 0.05 g, 0.57 mmol) 
according to General procedure (2.5h). Purified by column 
chromatography (1:4 EtOAc–heptane) to yield 43 mg 
(25 %) of 7c as a white amorphous product. Rf: 0.45 (1:1 
EtOAc–hexane); [α]D –6 (c 0.35, CHCl3). 1H NMR (250 
MHz, CDCl3) δ 7.36–6.95 (4H, m, aromatics), 6.61 (1H, d, 
J1,2 15.9 Hz, H-1), 6.09 (1H, dd, J2,3 7.8 Hz, H-2), 5.47 (1H, 
dd, J6,7 1.1 Hz, H-6), 5.24 (1H, pseudo t, J4,5 10.2 Hz, H-4), 
5.11 (1H, dd, J5,6 3.4 Hz, H-5), 4.21–4.09 (2H, m, H-8a, H-
8b), 4.06–3.93 (2H, m, H-3, H-7), 2.33 (3H, s, CH3), 2.17, 
2.04, 1.99, 1.94 (15H, 5s, 5×CH3). 13C NMR (63 MHz, 
CDCl3) δ 170.6, 170.4, 170.3, 169.8 (4×CO), 135.4 (C-1), 
138.4–124.0 (aromatics), 124.2 (C-2), 80.4 (C-3), 74.2 (C-
7), 71.9 (C-5), 68.9 (C-4), 67.9 (C-6), 61.9 (C-8), 21.5 
(CH3), 20.9, 20.8 (4×CH3). HR-ESI-MS positive mode 
(m/z): calcd. for: [M+Na]+=471.1626, found: 
[M+Na]+=471.1631; C23H28O9 (448.17). 
3,4,5,7-Tetra-O-acetyl-2,6-anhydro-N1-(3-
methylbenzyl)-D-glycero-L-manno-heptose 
tosylhydrazone (N1-3-methylbenzyl-C-(2,3,4,6-tetra-O-
acetyl-β-D-galactopyranosyl)formaldehyde 
tosylhydrazone) (9c) 
Isolated as a by-product beside 7c from the previous 
reaction mixture by column chromatography (1:4 EtOAc–
heptane) to yield 16 mg (7 %) of 9c as a white amorphous 
product. Rf: 0.36 (1:1 EtOAc–heptane); [α]D –10 (c 0.35, 
CHCl3).1H NMR (250 MHz, CDCl3) δ 7.83 (2H, d, J 8.3 
Hz, aromatics), 7.34 (2H, d, J 8.0 Hz, aromatics), 7.25–
6.97 (4H, m, aromatics), 6.66 (1H, d, J1,2 6.5 Hz, H-1), 
5.39 (1H, dd, J5,6 0.8 Hz, H-5), 5.10–5.00 (2H, strongly 
coupled, H-3, H-4), 4.94 (1H, d, JCH2a,CH2b 16.9 Hz, CH2a), 
4.60 (1H, d, CH2b), 4.03 (1H, dd, J7a,7b 12.5 Hz, H-7a), 3.98 
(1H, dd, H-7b), 3.93 (1H, strongly coupled, H-2), 3.86 (1H, 
ddd, J6,7a 6.5, J6,7b 6.8 Hz, H-6), 2.43 (3H, s, CH3-Ts), 2.34 
(3H, s, CH3), 2.10, 2.02, 1.95, 1.65 (12H, 4s, 4×CH3). 13C 
NMR (63 MHz, CDCl3) δ 170.5, 170.3, 170.1 (4×CO), 
139.9 (C-1), 144.5–123.3 (aromatics), 79.0 (C-2), 74.4 (C-
6), 71.3 (C-4), 67.6 (C-5), 67.0 (C-3), 61.6 (C-7), 51.1 
(CH2), 21.7 (CH3-Ts), 21.6 (CH3), 20.8, 20.7, 20.3 
(4×CH3). HR-ESI-MS positive mode (m/z): calcd. for: 
[M+Na]+=655.1932, found: [M+Na]+=655.1948; 
C30H26N2O11S (632.20). 
(E)-4,5,6,8-Tetra-O-acetyl-3,7-anhydro-(3-
chlorophenyl)-1,2-dideoxy-1-D-glycero-L-manno-oct-1-
enitol ((E)--(C-2,3,4,6-tetra-O-acetyl-β-D-
galactopyranosyl)-3-chlorostyrene) (7d) 
Prepared from tosylhydrazone 6 (0.20 g, 0.38 mmol), 1-
bromomethyl-3-chlorobenzene (6 equiv., 0.30 mL, 0.47 g, 
2.27 mmol) and LiOtBu (1.5 equiv., 0.05 g, 0.57 mmol) 
according to General procedure (4.5h). Purified by column 
chromatography (1:4 EtOAc–heptane) to yield 104 mg 
(59 %) of 7d as a yellow amorphous product. Rf: 0.42 (1:1 
EtOAc–hexane); [α]D –2 (c 0.80, CHCl3).1H NMR (250 
MHz, CDCl3) δ 7.60–7.12 (4H, m, aromatics), 6.59 (1H, d, 
J1,2 15.9 Hz, H-1), 6.12 (1H, dd, J2,3 7.5 Hz, H-2), 5.47 (1H, 
dd, J6,7 1.1 Hz, H-6), 5.23 (1H, pseudo t, J4,5 10.2 Hz, H-4), 
5.11 (1H, dd, J5,6 3.3 Hz, H-5), 4.17–4.10 (2H, m, H-8a, H-
8b), 4.05–3.93 (2H, m, H-3, H-7), 2.17, 2.04, 1.99, 1.96 
(12H, 4s, 4×CH3). 13C NMR (63 MHz, CDCl3) δ 170.6, 
170.4, 170.3, 169.8 (4×CO), 133.5 (C-1), 145.4–124.8 
(aromatics), 125.0 (C-2), 79.9 (C-3), 74.3 (C-7), 71.8 (C-5), 
68.8 (C-4), 67.8 (C-6), 61.9 (C-8), 20.9, 20.8 (4×CH3). 
HR-ESI-MS positive mode (m/z): calcd. for: 
[M+Na]+=491.1079, found: [M+Na]+=491.1077; 
C22H25ClO9 (468.12). 
(E)-4,5,6,8-Tetra-O-acetyl-3,7-anhydro-1-(4-
bromophenyl)-1,2-dideoxy-D-glycero-L-manno-oct-1-
enitol ((E)-4-bromo--(C-2,3,4,6-tetra-O-acetyl-β-D-
galactopyranosyl)styrene) (7e) 
Prepared from tosylhydrazone 6 (0.20 g, 0.38 mmol), 1-
bromomethyl-4-bromobenzene (6 equiv., 0.57 g, 2.27 
mmol) and LiOtBu (1.5 equiv., 0.05 g, 0.57 mmol) 
according to General procedure (2.5h). Purified by column 
chromatography (1:4 EtOAc–heptane) to yield 59 mg 
(31 %) of 7e as a pale yellow amorphous product. Rf: 0.42 
(1:1 EtOAc–hexane); [α]D –7 (c 0.80, CHCl3).1H NMR 
(400 MHz, CDCl3) δ 7.44 (2H, d, J 8.4 Hz, aromatics), 
7.23 (2H, d, J 8.4 Hz, aromatics), 6.60 (1H, d, J1,2 15.9 Hz, 
H-1), 6.11 (1H, dd, J2,3 7.7 Hz, H-2), 5.48 (1H, dd, J6,7 0.8 
Hz, H-6), 5.23 (1H, pseudo t, J4,5 10.2 Hz, H-4), 5.12 (1H, 
dd, J5,6 3.3 Hz, H-5), 4.19–4.09 (2H, m, H-8a, H-8b), 4.01 
(1H, dd, J2,3 9.7 Hz, H-3), 3.98 (1H, ddd, J6,7a 6.6, J6,7b 6.3 
Hz, H-7), 2.18, 2.05, 2.00, 1.95 (12H, 4s, 4×CH3). 13C 
NMR (63 MHz, CDCl3) δ 170.6, 170.4, 170.3, 169.8 
(4×CO), 133.8 (C-1), 145.4–122.8 (aromatics), 125.3 (C-2), 
80.1 (C-3), 74.3 (C-7), 71.8 (C-5), 68.8 (C-4), 67.8 (C-6), 
61.9 (C-9), 20.9, 20.8 (4×CH3). HR-ESI-MS positive mode 
(m/z): calcd. for: [M+Na]+=535.0574, found: 
[M+Na]+=535.0571; C22H25BrO9 (512.07). 
3,4,5,7-Tetra-O-acetyl-2,6-anhydro-N1-(4-
bromobenzyl)-D-glycero-L-manno-heptose 
tosylhydrazone (N1-4-bromobenzyl-C-(2,3,4,6-tetra-O-
acetyl-β-D-galactopyranosyl)formaldehyde 
tosylhydrazone) (9e) 
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Isolated as a by-product beside 7e from the previous 
reaction mixture by column chromatography (1:4 EtOAc–
heptane) to yield 24 mg (9 %) of 9e as a yellow amorphous 
product. Rf: 0.36 (1:1 EtOAc–hexane); [α]D –8 (c 0.60, 
CHCl3).1H NMR (400 MHz, CDCl3) δ 7.82 (2H, d, J 8.3 
Hz, aromatics), 7.49 (2H, d, J 8.4 Hz, aromatics), 7.35 (2H, 
d, J 8.1 Hz, aromatics), 7.16 (2H, d, J 8.4 Hz, aromatics), 
6.61 (1H, d, J1,2 6.5 Hz, H-1), 5.40 (1H, dd, J5,6 1.0 Hz, H-
5), 5.04 (1H, dd, J4,5 4.8 Hz, H-4), 5.03 (1H, pseudo t, J3,4 
10.2 Hz, H-3), 4.92 (1H, d, JCH2a,CH2b 16.9 Hz, CH2a), 4.56 
(1H, d, CH2b), 4.03 (1H, dd, J7a,7b 13.4 Hz, H-7a), 4.00 (1H, 
dd, H-7b), 3.92 (1H, strongly coupled, H-2), 3.87 (1H, ddd, 
J6,7a 6.8, J6,7b 6.3 Hz, H-6), 2.44, (3H, s, CH3-Ts), 2.12, 
2.03, 1.96, 1.64 (12H, 4s, 4×CH3). 13C NMR (63 MHz, 
CDCl3) δ 170.9, 170.5, 170.2, 170.1 (4×CO), 140.2 (C-1), 
144.7–121.6 (aromatics), 78.9 (C-2), 74.5 (C-6), 71.1 (C-4), 
67.5 (C-5), 67.1 (C-3), 61.6 (C-7), 50.5 (CH2), 21.7 (CH3-
Ts), 20.8, 20.7, 20.3 (4×CH3). HR-ESI-MS positive mode 
(m/z): calcd. for: [M+Na]+=719.0881, found: 
[M+Na]+=719.0879; C29H33BrN2O11S (696.10). 
N1-Allyl-2,6-anhydro-3,4,5,7-tetra-O-benzoyl-D-glycero-
D-gulo-heptose tosylhydrazone (N1-allyl-C-(2,3,4,6-
tetra-O-benzoyl-β-D-glucopyranosyl)formaldehyde 
tosylhydrazone) (10) 
Prepared from tosylhydrazone 1 (0.20 g, 0.26 mmol), 3-
bromoprop-1-ene (6 equiv., 0.13 mL, 0.19 g, 1.54 mmol) 
and LiOtBu (1.5 equiv., 0.03 g, 0.39 mmol) according to 
General procedure (22h). Purified by column 
chromatography (1:8 EtOAc–hexane) to yield 40 mg 
(18 %) of 10 as a yellow amorphous product. Rf: 0.33 (1:2 
EtOAc–hexane); [α]D +1 (c 0.79, CHCl3). 1H NMR (400 
MHz, CDCl3) δ 8.14–7.69 (8H, m, aromatics), 7.63–7.20 
(14H, m, aromatics), 6.94 (1H, d, J1,2 6.7 Hz, H-1), 6.86 
(2H, d, J 8.1 Hz, aromatics), 5.93 (1H, pseudo t, J4,5 9.7 Hz, 
H-4), 5.69 (1H, pseudo t, J5,6 10.0 Hz, H-5), 5.66–5.59 (1H, 
m, CH), 5.46 (1H, pseudo t, J3,4 9.7 Hz, H-3), 5.20–5.07 
(2H, m, CH2), 4.58 (1H, dd, J7a,7b 12.3 Hz, H-7a), 4.45 (1H, 
dd, H-7b), 4.39 (1H, dd, J2,3 9.8 Hz, H-2), 4.36–4.26 (1H, 
m, CH2a), 4.25–4.18 (1H, m, CH2b), 4.17 (1H, ddd, J6,7a 2.5, 
J6,7b 5.0 Hz, H-6), 2.19 (3H, s, CH3). 13C NMR (100 MHz, 
CDCl3) δ 166.3, 165.9, 165.5, 165.3 (4×CO), 139.5 (C-1), 
144.0–126.5 (aromatics, CH), 118.4 (CH2), 78.9 (C-2), 
76.3 (C-6), 73.8 (C-4), 71.0 (C-3), 69.4 (C-5), 63.3 (C-7), 
49.0 (CH2), 21.7 (CH3). HR-ESI-MS positive mode (m/z): 
calcd. for: [M+Na]+=839.2245, found: 
[M+Na]+=839.2240; C45H40N2O11S (816.24). 
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